<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2187">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04402853</url>
  </required_header>
  <id_info>
    <org_study_id>72/2020</org_study_id>
    <nct_id>NCT04402853</nct_id>
  </id_info>
  <brief_title>SARS Cov-2 in Conjunctival Secretion</brief_title>
  <official_title>SARS Cov-2 in Conjunctival Secretions in an Italian Lombardia Cohort of Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi dell'Insubria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi dell'Insubria</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study to evaluate the presence of SARS COV-2 in tears collected in COVID-19
      patients in Lombardia region, northern Italy, and to correlate virus presence to concomitant
      systemic clinical conditions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since February 2020, Coronavirurus Disease 2019 associated to a severe acute respiratory
      syndrome started in China and rapidly spread all over the world and in particular in northern
      Italy. There are many reasons to justify this rapid diffusion in Italian Lombardia region as
      the high population density with more possibilities of interpersonal contact, high prevalence
      of respiratory pathologies, in particular in elderly people, due to pollution, high number of
      contacts with Chinese population for travelling and business reasons, and at last the
      non-windy temperate climate conditions, that increases the persistence of virus in the
      environment.

      At now, more than eighty thousand citizens from Lombardia Region have been officially
      affected by the disease with a high death toll, also considering that actual numbers are
      certainly much underestimated.

      The aim of the present study was to evaluate the prevalence of SARS COV-2 virus in tears
      collected from COVID-19 patients by rtPCR analysis directed to target sites of viral RNA, and
      to correlate virus presence to concomitant systemic clinical conditions
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Actual">May 20, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Virus presence in COVID 19 patients tears</measure>
    <time_frame>1 day</time_frame>
    <description>prevalence of SARS CoV 2 virus on tears</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concordance to Naso-Pharingeal Swab</measure>
    <time_frame>1 day</time_frame>
    <description>Evaluation of concordance with Naso-Pharingeal testing</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Sars-CoV2</condition>
  <condition>Tear</condition>
  <arm_group>
    <arm_group_label>COVID 19 Patients</arm_group_label>
    <description>hospitalized patients with COVID 19</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Tears swab</intervention_name>
    <description>rtPCR on tears swabs samples</description>
    <arm_group_label>COVID 19 Patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tears
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized patients with a confirmed diagnosis of COVID 19 pneumonia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hospitalized COVID 19 patients

        Exclusion Criteria:

          -  Patients with respiratory support that interferes with tears sampling
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simone Donati, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Insubria, Varese</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ASST Sette Laghi</name>
      <address>
        <city>Varese</city>
        <zip>21100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>https://www.healio.com/ophthalmology/cornea-external-disease/news/online/%7Bb388d413-6068-4ed7-8a29-f979d33ef1a0%7D/covid-19-possibly-identified-in-tears-conjunctival-secretions</url>
    <description>tears and infection</description>
  </link>
  <reference>
    <citation>Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, Wu K. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020 May 1;138(5):575-578. doi: 10.1001/jamaophthalmol.2020.1291.</citation>
    <PMID>32232433</PMID>
  </reference>
  <results_reference>
    <citation>Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020 Apr 26. doi: 10.1111/aos.14445. [Epub ahead of print]</citation>
    <PMID>32336042</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 22, 2020</study_first_submitted>
  <study_first_submitted_qc>May 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2020</study_first_posted>
  <last_update_submitted>May 22, 2020</last_update_submitted>
  <last_update_submitted_qc>May 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi dell'Insubria</investigator_affiliation>
    <investigator_full_name>Simone Donati</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>COVID 19</keyword>
  <keyword>EYE</keyword>
  <keyword>Tears</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The study will be published</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

